Explore › Finding
Finding improvement
Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.
Effect sizeCOMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
Follow-up12 weeks
ComparatorPill placebo with identical medication management schedule
Effect summaryimprovement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Connected entities

Interventions
Sertraline
Conditions
Anxiety Disorders
Outcomes
youth depressive symptoms
Populations
Adolescents

Source

PMC6425733
Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice
Read on PMC → · View in graph →